Aviation Medication Transparency Act of 2025

Bill 119 hr 2592, also known as the "FAA Medications List Transparency Act," aims to increase transparency within the Federal Aviation Administration (FAA) by requiring the Administrator to publish a list of medications that are compiled for the medical certification of airmen. This list will provide pilots and other aviation personnel with clear guidelines on which medications are acceptable for use while maintaining their certification.

The bill emphasizes the importance of ensuring that airmen are aware of which medications may impact their ability to safely operate aircraft. By making this information readily available, the FAA can help prevent potential conflicts between medication use and aviation safety.

In addition to publishing the medications list, the bill also includes provisions for other purposes related to medical certification of airmen. This may include updates to existing regulations, guidelines for medical evaluations, or other measures aimed at improving the overall safety and well-being of aviation personnel. Overall, Bill 119 hr 2592 seeks to promote transparency and accountability within the FAA, while also prioritizing the safety and health of airmen. By providing clear information on acceptable medications, the bill aims to enhance aviation safety and ensure that pilots are able to perform their duties effectively and responsibly.